Escitalopram for the Treatment of Depression in Alzheimer's Disease

Summary

Purpose : to Evaluation of the Efficacy of Escitalopram for the Treatment of Depression in Alzheimer's Disease Trial Design : A 12-week, randomized, double-blind, parallel-group, placebo-controlled trial with an open-label, 12-week extension

Timeline

Start

2011-11

Primary completion

2014-07

Completion

2014-07

Drugs

Indications